Seòmar agus comataidhean

In that case, I call Stephanie Callaghan to ask about health inequalities.

We will shortly be moving on to technology questions from David Torrance, but Emma wants to come back in.

We were scheduled to finish around now, but if members approve, we will continue so that we can cover the very important topic of women’s health. We should finish in about 15 minutes, but I really want to give the issue an airing.

First, I declare that I was on the cross-party group on women’s health. That group called for a women’s health plan, so I am pleased that such a plan will—we hope—be in the programme for government. A number of members have questions on the plan. I call Gillian Mackay first.

We move on to questions on mental health.

Thank you.

That would be helpful. Of course, we will come back to the women’s health plan in detail at a later point.

That rounds off our questions on the women’s health plan, but Annie Wells has a final question on the health and wellbeing of staff.

Item 3 is consideration of subordinate legislation. There are two negative instruments for us to consider. The first instrument amends the National Health Service (Travelling Expenses and Remission of Charges) (Scotland) (No 2) Regulations 2003 to make free dental care available to people who are aged between 18 and 25 years. The second instrument amends the Milk and Healthy Snack Scheme (Scotland) Regulations 2021. Its aim is to clarify and address technical issues with the operation of the milk and healthy snack scheme.

The Delegated Powers and Law Reform Committee considered the two instruments, and both instruments were reported under reporting ground (j), for their failure to comply with the 28-day laying period. No motions to annul have been received in relation to the instruments.

Do members have any comments on either of the instruments?

Yes, that is correct—it was due to the pandemic.

I see that there are no other comments or questions. Therefore, I propose that the committee makes no recommendations in relation to these negative instruments. Does any member disagree?

I see that there is full agreement.

At our next meeting on 14 September, the committee will hear from the Minister for Drugs Policy, Angela Constance, on her priorities for session 6. That concludes the public part of our meeting today.

That would be helpful. I will bring in Professor Leitch.